Global Healthcare Nanotechnology (Nanomedicine) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 150461
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 117
  • list Pharmaceuticals and Healthcare

Nanomedicine is a promising mode of cancer treatment. With the advantage of the properties of matter at nanoscale, nanomedicine promises to develop innovative drugs with greater efficacy and lesser side effects than standard therapies.

Scope of the Report:

This report studies the Healthcare Nanotechnology (Nanomedicine) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Healthcare Nanotechnology (Nanomedicine) market by product type and applications/end industries.

The global Healthcare Nanotechnology (Nanomedicine) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Healthcare Nanotechnology (Nanomedicine).

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Abbott Laboratories

Combimatrix Corporation

GE Healthcare

Sigma-Tau Pharmaceuticals Inc.

Johnson & Johnson

Mallinckrodt Plc

Merck & Company Inc.

Nanosphere Inc.

Pfizer, Inc.

Celgene Corporation

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Biochip

Implant Materials

Medical Textiles

Wound Dressing

Other

Market Segment by Applications, can be divided into

Therapeutic

Diagnostic

Research

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Healthcare Nanotechnology (Nanomedicine) Market Overview

1.1 Product Overview and Scope of Healthcare Nanotechnology (Nanomedicine)

1.2 Classification of Healthcare Nanotechnology (Nanomedicine) by Types

1.2.1 Global Healthcare Nanotechnology (Nanomedicine) Revenue Comparison by Types (2017-2023)

1.2.2 Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Types in 2017

1.2.3 Biochip

1.2.4 Implant Materials

1.2.5 Medical Textiles

1.2.6 Wound Dressing

1.2.7 Other

1.3 Global Healthcare Nanotechnology (Nanomedicine) Market by Application

1.3.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Therapeutic

1.3.3 Diagnostic

1.3.4 Research

1.4 Global Healthcare Nanotechnology (Nanomedicine) Market by Regions

1.4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Healthcare Nanotechnology (Nanomedicine) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Healthcare Nanotechnology (Nanomedicine) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Healthcare Nanotechnology (Nanomedicine) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Healthcare Nanotechnology (Nanomedicine) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Healthcare Nanotechnology (Nanomedicine) Status and Prospect (2013-2023)

1.5 Global Market Size of Healthcare Nanotechnology (Nanomedicine) (2013-2023)

2 Manufacturers Profiles

2.1 Abbott Laboratories

2.1.1 Business Overview

2.1.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Laboratories Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Combimatrix Corporation

2.2.1 Business Overview

2.2.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Combimatrix Corporation Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.3 GE Healthcare

2.3.1 Business Overview

2.3.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GE Healthcare Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sigma-Tau Pharmaceuticals Inc.

2.4.1 Business Overview

2.4.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sigma-Tau Pharmaceuticals Inc. Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Johnson & Johnson

2.5.1 Business Overview

2.5.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Mallinckrodt Plc

2.6.1 Business Overview

2.6.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Mallinckrodt Plc Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck & Company Inc.

2.7.1 Business Overview

2.7.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck & Company Inc. Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Nanosphere Inc.

2.8.1 Business Overview

2.8.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Nanosphere Inc. Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.9 Pfizer, Inc.

2.9.1 Business Overview

2.9.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Pfizer, Inc. Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

2.10 Celgene Corporation

2.10.1 Business Overview

2.10.2 Healthcare Nanotechnology (Nanomedicine) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Celgene Corporation Healthcare Nanotechnology (Nanomedicine) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Healthcare Nanotechnology (Nanomedicine) Market Competition, by Players

3.1 Global Healthcare Nanotechnology (Nanomedicine) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Healthcare Nanotechnology (Nanomedicine) Players Market Share

3.2.2 Top 10 Healthcare Nanotechnology (Nanomedicine) Players Market Share

3.3 Market Competition Trend

4 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Regions

4.1 Global Healthcare Nanotechnology (Nanomedicine) Revenue and Market Share by Regions

4.2 North America Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

4.3 Europe Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

4.5 South America Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

5 North America Healthcare Nanotechnology (Nanomedicine) Revenue by Countries

5.1 North America Healthcare Nanotechnology (Nanomedicine) Revenue by Countries (2013-2018)

5.2 USA Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

5.3 Canada Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

5.4 Mexico Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

6 Europe Healthcare Nanotechnology (Nanomedicine) Revenue by Countries

6.1 Europe Healthcare Nanotechnology (Nanomedicine) Revenue by Countries (2013-2018)

6.2 Germany Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

6.3 UK Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

6.4 France Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

6.5 Russia Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

6.6 Italy Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Revenue by Countries

7.1 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Revenue by Countries (2013-2018)

7.2 China Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

7.3 Japan Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

7.4 Korea Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

7.5 India Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

8 South America Healthcare Nanotechnology (Nanomedicine) Revenue by Countries

8.1 South America Healthcare Nanotechnology (Nanomedicine) Revenue by Countries (2013-2018)

8.2 Brazil Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

8.3 Argentina Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

8.4 Colombia Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Healthcare Nanotechnology (Nanomedicine) by Countries

9.1 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

9.3 UAE Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

9.4 Egypt Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

9.6 South Africa Healthcare Nanotechnology (Nanomedicine) Revenue and Growth Rate (2013-2018)

10 Global Healthcare Nanotechnology (Nanomedicine) Market Segment by Type

10.1 Global Healthcare Nanotechnology (Nanomedicine) Revenue and Market Share by Type (2013-2018)

10.2 Global Healthcare Nanotechnology (Nanomedicine) Market Forecast by Type (2018-2023)

10.3 Biochip Revenue Growth Rate (2013-2023)

10.4 Implant Materials Revenue Growth Rate (2013-2023)

10.5 Medical Textiles Revenue Growth Rate (2013-2023)

10.6 Wound Dressing Revenue Growth Rate (2013-2023)

10.7 Other Revenue Growth Rate (2013-2023)

11 Global Healthcare Nanotechnology (Nanomedicine) Market Segment by Application

11.1 Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Application (2013-2018)

11.2 Healthcare Nanotechnology (Nanomedicine) Market Forecast by Application (2018-2023)

11.3 Therapeutic Revenue Growth (2013-2018)

11.4 Diagnostic Revenue Growth (2013-2018)

11.5 Research Revenue Growth (2013-2018)

12 Global Healthcare Nanotechnology (Nanomedicine) Market Size Forecast (2018-2023)

12.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size Forecast (2018-2023)

12.2 Global Healthcare Nanotechnology (Nanomedicine) Market Forecast by Regions (2018-2023)

12.3 North America Healthcare Nanotechnology (Nanomedicine) Revenue Market Forecast (2018-2023)

12.4 Europe Healthcare Nanotechnology (Nanomedicine) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Healthcare Nanotechnology (Nanomedicine) Revenue Market Forecast (2018-2023)

12.6 South America Healthcare Nanotechnology (Nanomedicine) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Healthcare Nanotechnology (Nanomedicine) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Healthcare Nanotechnology (Nanomedicine) Picture

Table Product Specifications of Healthcare Nanotechnology (Nanomedicine)

Table Global Healthcare Nanotechnology (Nan

Please fill the form below, to recieve the report sample


+1